Correlation Between Pfizer and BioRem

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and BioRem at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and BioRem into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc CDR and BioRem Inc, you can compare the effects of market volatilities on Pfizer and BioRem and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of BioRem. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and BioRem.

Diversification Opportunities for Pfizer and BioRem

-0.8
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Pfizer and BioRem is -0.8. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc CDR and BioRem Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioRem Inc and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc CDR are associated (or correlated) with BioRem. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioRem Inc has no effect on the direction of Pfizer i.e., Pfizer and BioRem go up and down completely randomly.

Pair Corralation between Pfizer and BioRem

Assuming the 90 days trading horizon Pfizer Inc CDR is expected to under-perform the BioRem. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc CDR is 2.37 times less risky than BioRem. The stock trades about -0.1 of its potential returns per unit of risk. The BioRem Inc is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  237.00  in BioRem Inc on September 5, 2024 and sell it today you would earn a total of  60.00  from holding BioRem Inc or generate 25.32% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc CDR  vs.  BioRem Inc

 Performance 
       Timeline  
Pfizer Inc CDR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc CDR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.
BioRem Inc 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in BioRem Inc are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, BioRem showed solid returns over the last few months and may actually be approaching a breakup point.

Pfizer and BioRem Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and BioRem

The main advantage of trading using opposite Pfizer and BioRem positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, BioRem can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioRem will offset losses from the drop in BioRem's long position.
The idea behind Pfizer Inc CDR and BioRem Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios